Mozart Therapeutics Logo Skip to main content
  • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Investment Partners
  • Science
    • Regulatory CD8 T cell network
    • Our Approach
    • Posters and Publications
  • Pipeline
    • Pipeline
    • KIR CD8 Treg Modulator
  • News
    • Press Releases
  • Careers
    • Job Opportunities
    • Values
    • Benefits
  • Contact

News

MEDIA CONTACT

For media inquiries:
media@mozart-tx.com

Press Releases

May 18, 2022

Mozart Therapeutics to Present on Novel CD8 T Cell Network at the 2022 Digestive Disease Week® (DDW) Conference

May 10, 2022

Mozart Therapeutics Presents Data at IMMUNOLOGY™ 2022 Highlighting Novel CD8 Treg Network in Celiac Disease and Other Autoimmune Diseases

March 21, 2022

Mozart Therapeutics Announces Appointment of Jan Beck as Chief Operating Officer

More Press Releases

  • Home
  • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Investment Partners
  • Science
    • Regulatory CD8 T cell network
    • Our Approach
    • Posters and Publications
  • Pipeline
    • Pipeline
    • KIR CD8 Treg Modulator
  • News
    • Press Releases
  • Careers
    • Job Opportunities
    • Values
    • Benefits
  • Contact
Logo© 2022 Mozart Therapeutics All rights reservedWebsite Design: Hane Chow, Inc.